296 related articles for article (PubMed ID: 25516438)
1. Potential reduction of interstitial myocardial fibrosis with renal denervation.
Doltra A; Messroghli D; Stawowy P; Hassel JH; Gebker R; Leppänen O; Gräfe M; Schneeweis C; Schnackenburg B; Fleck E; Kelle S
J Am Heart Assoc; 2014 Dec; 3(6):e001353. PubMed ID: 25516438
[TBL] [Abstract][Full Text] [Related]
2. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
3. Renal denervation to treat cardiac fibrosis?
Wehner P; Shapiro JI
J Am Heart Assoc; 2014 Dec; 3(6):e001556. PubMed ID: 25516440
[No Abstract] [Full Text] [Related]
4. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.
Brandt MC; Mahfoud F; Reda S; Schirmer SH; Erdmann E; Böhm M; Hoppe UC
J Am Coll Cardiol; 2012 Mar; 59(10):901-9. PubMed ID: 22381425
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes.
Rodrigues JC; Amadu AM; Dastidar AG; Szantho GV; Lyen SM; Godsave C; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Nightingale AK; Paton JF; Manghat NE; Bucciarelli-Ducci C
Heart; 2016 Oct; 102(20):1671-9. PubMed ID: 27260191
[TBL] [Abstract][Full Text] [Related]
6. Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.
Ambale Venkatesh B; Volpe GJ; Donekal S; Mewton N; Liu CY; Shea S; Liu K; Burke G; Wu C; Bluemke DA; Lima JA
Hypertension; 2014 Sep; 64(3):508-15. PubMed ID: 24914198
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt.
Pereda D; García-Lunar I; Sierra F; Sánchez-Quintana D; Santiago E; Ballesteros C; Encalada JF; Sánchez-González J; Fuster V; Ibáñez B; García-Álvarez A
Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27601365
[TBL] [Abstract][Full Text] [Related]
8. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
9. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S
Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307
[TBL] [Abstract][Full Text] [Related]
10. Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
Treibel TA; Zemrak F; Sado DM; Banypersad SM; White SK; Maestrini V; Barison A; Patel V; Herrey AS; Davies C; Caulfield MJ; Petersen SE; Moon JC
J Cardiovasc Magn Reson; 2015 Aug; 17(1):74. PubMed ID: 26264919
[TBL] [Abstract][Full Text] [Related]
11. Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.
Kwiecinski J; Lennen RJ; Gray GA; Borthwick G; Boswell L; Baker AH; Newby DE; Dweck MR; Jansen MA
J Cardiovasc Magn Reson; 2020 Aug; 22(1):57. PubMed ID: 32758255
[TBL] [Abstract][Full Text] [Related]
12. Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain.
Niu J; Zeng M; Wang Y; Liu J; Li H; Wang S; Zhou X; Wang J; Li Y; Hou F; Zhu J
BMC Cardiovasc Disord; 2020 Jun; 20(1):292. PubMed ID: 32539749
[TBL] [Abstract][Full Text] [Related]
13. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction.
Schirmer SH; Sayed MM; Reil JC; Ukena C; Linz D; Kindermann M; Laufs U; Mahfoud F; Böhm M
J Am Coll Cardiol; 2014 May; 63(18):1916-23. PubMed ID: 24315919
[TBL] [Abstract][Full Text] [Related]
14. Temporal alterations in cardiac fibroblast function following induction of pressure overload.
Stewart JA; Massey EP; Fix C; Zhu J; Goldsmith EC; Carver W
Cell Tissue Res; 2010 Apr; 340(1):117-26. PubMed ID: 20217135
[TBL] [Abstract][Full Text] [Related]
15. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
[TBL] [Abstract][Full Text] [Related]
16. Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study.
Iyer NR; Le TT; Kui MSL; Tang HC; Chin CT; Phua SK; Bryant JA; Pua CJ; Ang B; Toh DF; Aw TC; Lee CH; Cook SA; Ugander M; Chin CWL
Hypertension; 2022 Aug; 79(8):1804-1813. PubMed ID: 35603595
[TBL] [Abstract][Full Text] [Related]
17. Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering.
McLellan AJ; Schlaich MP; Taylor AJ; Prabhu S; Hering D; Hammond L; Marusic P; Duval J; Sata Y; Ellims A; Esler M; Peter K; Shaw J; Walton A; Kalman JM; Kistler PM
Heart Rhythm; 2015 May; 12(5):982-90. PubMed ID: 25638699
[TBL] [Abstract][Full Text] [Related]
18. Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis.
Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Morczeck K; Wiebe J; Hoffmann J; Voss S; Bauer T; Hamm C; Nef H
Am J Hypertens; 2015 Oct; 28(10):1285-92. PubMed ID: 25767136
[TBL] [Abstract][Full Text] [Related]
19. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
[TBL] [Abstract][Full Text] [Related]
20. Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
aus dem Siepen F; Buss SJ; Andre F; Seitz S; Giannitsis E; Steen H; Katus HA; Kristen AV
Clin Res Cardiol; 2015 Aug; 104(8):640-7. PubMed ID: 25855392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
